Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies today with an urgent need for novel therapeutic strategies. Biomarker analysis helps to better understand tumor biology and might emerge as a tool to develop personalized therapies. The aim of the study is to...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: Popp, Felix C., Popp, Marie Christine, Zhao, Yue, Betzler, Christopher, Kropf, Siegfried, Garlipp, Benjamin, Benckert, Christoph, Kalinski, Thomas, Lippert, Hans, Bruns, Christiane J.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Study Protocol
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5371262/
https://ncbi.nlm.nih.gov/pubmed/28356064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3186-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料